Tom Brady-backed telehealth firm eMed valued at over $2 billion in latest funding round
By Bullbit Editorial · March 26, 2026
WhatTom Brady-backed telehealth firm eMed has secured a valuation of over $2 billion following its latest funding round.
WhyThe firm's valuation surge is attributed to its growing presence in the telehealth market and increasing demand for remote healthcare services.
SignaleMed's partnership with prominent investors, including Tom Brady, has helped attract significant funding and boost its market value.
TargetThe company plans to utilize the funding to expand its services and improve its technology infrastructure, aiming to reach **10 million** patients by the end of **2027**.
RiskRegulatory challenges and increased competition in the telehealth market pose significant risks to eMed's growth and valuation.